Pinnacle Wealth Planning Services’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-297
Closed -$21.4K 2837
2025
Q4
$21.4K Buy
+297
New +$19.2K ﹤0.01% 1683

Other funds holding RNAM

Pinnacle Wealth Planning Services's RNAM Position: Q1 2026 in Review

Pinnacle Wealth Planning Services sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 297 shares — an estimated $21.4K sold.

Pinnacle Wealth Planning Services first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $21.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Pinnacle Wealth Planning Services reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 297 Avidity Biosciences shares in Q1 2026, an estimated $21.4K.
  • Pinnacle Wealth Planning Services first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Pinnacle Wealth Planning Services's Avidity Biosciences position peaked at $21.4K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.